Association of arterial fibrillation and immunosenescence in older patients

Association of arterial fibrillation and immunosenescence in older patients - AFIS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028105

Enrollment

150

Registered

2022-03-03

Start date

2022-02-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Group 1: Patients with atrial fibrillation are examined and blood is drawn. Group 2: Patients without atrial fibrillation are examined and blood is drawn.

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age = 60 years - MMSE = 24 (cognition) - no acute delirium - no palliative care - no sepsis

Exclusion criteria

Exclusion criteria: - Age < 60 years - MMSE < 24 (cognition) - acute delirium - palliative care - sepsis

Design outcomes

Primary

Measure	Time frame
Quantifying and comparing immunosenescence parameter of patients with and without atrial fibrillation	—

Secondary

Measure	Time frame
Association of atrial fibrillation and frailty Association of immunosenescence and frailty Association of immunosenescence and wound healing disorder	—

Countries

Germany

Contacts

Public ContactKristina Norman

Charité-Universitätsmedizin BerlinKlinik für Geriatrie und Altersmedizin

kristina.norman@charite.de030450529009

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 25, 2026